Assura Plc (LON:AGR – Get Free Report) shares were up 11.6% on Monday . The stock traded as high as GBX 46.20 ($0.58) and last traded at GBX 43.52 ($0.55). Approximately 212,891,641 shares changed hands during mid-day trading, an increase of 1,382% from the average daily volume of 14,366,552 shares. The stock had previously closed at GBX 39 ($0.49).
Assura Price Performance
The firm’s 50-day moving average is GBX 37.66 and its two-hundred day moving average is GBX 39.72. The company has a market cap of £1.42 billion, a P/E ratio of -41.60, a PEG ratio of 3.60 and a beta of 0.37. The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84.
Assura Dividend Announcement
The firm also recently declared a dividend, which was paid on Wednesday, January 15th. Investors of record on Thursday, December 12th were given a GBX 0.84 ($0.01) dividend. This represents a yield of 2.12%. The ex-dividend date was Thursday, December 12th. Assura’s dividend payout ratio is presently -286.76%.
Assura Company Profile
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- How to Short Nasdaq: An Easy-to-Follow Guide
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- ETF Screener: Uses and Step-by-Step Guide
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.